Hearing Aids for Dementia: What the Research Shows and How to Choose One in 2026

By Editorial Team · Updated July 26, 2026

Affiliate disclosure: We independently research and test every product. When you buy through links on this page, we may earn a commission at no extra cost to you. Learn more.

Quick Answer: Untreated hearing loss is the largest modifiable midlife risk factor for dementia, according to the 2024 Lancet Commission, and the Johns Hopkins ACHIEVE trial (a 3-year randomized controlled trial of 977 older adults) found that treating hearing loss slowed cognitive decline by 48% in participants with elevated dementia risk, rising to 58% in the highest-risk group. That trial used professionally fitted devices with ongoing support, not bare self-fitting OTC aids, so the best 2026 approach is either a clinically fitted hearing aid or an OTC model with real teleaudiology follow-up such as Jabra Enhance Select. For someone who already has a dementia diagnosis, prioritize simplicity over features: rechargeable batteries, a “set it and leave it” fit, and caregiver-accessible remote adjustment.

Hearing loss and cognitive decline get confused constantly, by families and sometimes by clinicians, because the symptoms overlap: withdrawing from conversation, seeming distracted, giving odd answers to questions. Increasingly, research says the confusion runs deeper than symptom overlap — hearing loss is not just a look-alike for dementia, it is one of its biggest known risk factors, and treating it is one of the few interventions with trial evidence behind it. This guide covers what the research actually found, what it did not find, and how to choose a hearing aid whether you are trying to protect your own cognition or fitting a device for a family member who has already been diagnosed.

Hearing loss and dementia, by the numbers

45% of dementia cases are potentially preventable by addressing 14 modifiable risk factors across the life course, according to the 2024 Lancet Commission on dementia prevention, intervention and care — and hearing loss is the single largest of those 14 factors from midlife onward.
48% slower cognitive decline over 3 years in older adults with elevated dementia risk factors who received a hearing intervention, versus a health-education control group, per the Johns Hopkins ACHIEVE trial (Aging and Cognitive Health Evaluation in Elders), published in The Lancet and Neurology.
58% slower decline in the highest-risk quarter of ACHIEVE participants — the benefit scaled with baseline risk, and was not statistically significant in the subset of healthy volunteers with fewer risk factors to begin with.
977 adults aged 70–84 with untreated mild-to-moderate hearing loss were randomized in ACHIEVE, one of the largest hearing-and-cognition trials run to date, with 3 years of follow-up.
~28.8 million U.S. adults could benefit from hearing aids, per the NIDCD, and hearing loss prevalence rises sharply with age — roughly two-thirds of adults over 70 have some degree of hearing loss, the same age band where dementia risk begins climbing fastest.

What the ACHIEVE trial actually found (and didn’t)

It’s worth being precise here, because headlines compressed a nuanced result into “hearing aids prevent dementia,” which overstates it. ACHIEVE randomized cognitively healthy older adults with untreated hearing loss into two groups: one received a full hearing intervention (audiologist-fitted devices plus counseling), the other received health education. Over 3 years, the trial measured cognitive decline in both.

The headline result was a 48% slower rate of cognitive decline in participants drawn from the ARIC cohort, an older, community-based group with more baseline cardiovascular and dementia risk factors. In the separate group of healthy volunteers recruited specifically for the trial, who had fewer risk factors on average, the hearing intervention did not produce a statistically significant difference. A follow-up analysis found the benefit scaled with risk: participants in the top quartile of dementia risk saw 58% slower decline, while lower-risk participants saw little measurable effect over the 3-year window.

The practical takeaway: treating hearing loss appears to meaningfully protect cognition in people who are already at elevated risk — older, with cardiovascular risk factors, lower baseline cognitive scores — and there is essentially no scenario where treating hearing loss is a bad idea. But it is not a proven, universal dementia vaccine, and no reputable source should sell it as one.

Jabra Enhance Select — teleaudiology support built in

Remote care from licensed hearing professionals · self-fitting app · from ~$1,195/pair

Closest OTC match to the "best-practice intervention" model used in ACHIEVE: real hearing professionals available by phone/video, not just an app.
100-day trial and a 3-year warranty make it a reasonable starting point for a first-time buyer worried about cognitive health, not just convenience.
See our full [Jabra hearing aids](/best/jabra-hearing-aids/) review for current lineup and pricing.

Check price on Amazon →

Ordering hearing aids or accessories for an aging parent often means you need them fast, not in two weeks — try Amazon Prime free for 30 days to get devices and spare domes delivered in two days.

Choosing a hearing aid to protect your own cognition

If you are an older adult with perceived mild-to-moderate hearing loss and no cognitive concerns yet, the ACHIEVE evidence argues for treating hearing loss sooner rather than later, and for choosing a device with real follow-up support over the cheapest bare-bones option:

Priority	Why it matters for cognitive health	What to look for
Consistent daily use	ACHIEVE measured continuous, everyday hearing correction, not occasional use	A fit comfortable enough to wear 8+ hours a day — see [best hearing aids for seniors](/best/best-hearing-aids-for-seniors/)
Real follow-up support	The trial's devices were professionally fitted and adjusted over time, not set once and forgotten	Brands with teleaudiology, such as Jabra Enhance or Signia TeleCare
Correct amplification	Under-amplified aids reduce social engagement, which is itself a Lancet-listed dementia risk factor	A proper hearing test — in-app or clinical, not guesswork
Bluetooth / streaming	Encourages continued conversation, calls and audio use rather than avoidance	See [best Bluetooth hearing aids](/best/best-bluetooth-hearing-aids/)

Choosing a hearing aid for someone who already has dementia

This is a different problem than buying for yourself, and most hearing aid buying guides don’t address it. The device that’s best for a tech-comfortable 68-year-old is often the wrong device for their 84-year-old parent with moderate dementia.

Get a real hearing test first, not a self-assessment. OTC hearing aids are built around the wearer’s own perception of their hearing loss and their ability to fine-tune the device through an app — both of which become unreliable once cognition is impaired. A person with dementia may not reliably report whether sound is too loud, too quiet, or distorted. A clinical audiologist can measure hearing loss objectively and fit a device that doesn’t depend on the wearer’s feedback.

Favor rechargeable over disposable batteries. Size 10, 13, 312 and 675 disposable batteries are small enough to be a choking or swallowing hazard, and a person with dementia may not manage the polarity or insertion correctly. A rechargeable model that goes in a charging case overnight removes a daily task that can go wrong.

Set it once, then leave it alone. Devices built around constant self-fitting and daily app tweaks work against a person who can’t reliably operate a phone. Look for a model that can be programmed to a fixed, professionally verified setting.

Get caregiver-accessible remote adjustment if the budget allows. Platforms like ReSound Assist Live (used by Jabra Enhance) and Signia TeleCare let a family member or audiologist request or make adjustments remotely, without the person with dementia needing to operate anything. Our hearing aid apps guide covers which platforms support this.

Consider a caregiver-side physical remote over relying on the wearer’s phone. A large-button remote that a caregiver keeps and operates is often more reliable day to day than expecting a person with dementia to find, unlock and navigate a smartphone app — see our best hearing aid remote controls guide.

Situation	Recommended approach
Early-stage dementia, engaged and tech-comfortable	App-based OTC device with teleaudiology support, caregiver keeps admin access to the app
Moderate dementia, needs a fixed setting	Clinically fitted prescription hearing aid, programmed once by an audiologist
Any stage, caregiver managing day to day	Rechargeable device + physical caregiver remote instead of relying on the wearer's phone
Advanced dementia, in a care facility	Consult the facility and an audiologist directly — device retention and daily wear compliance become the main obstacle, not the hardware

Is it hearing loss or is it dementia?

Because the symptoms look alike, families often assume the worst before ruling out the simpler explanation. A rough distinguishing sign: someone with primarily a hearing problem usually follows a quiet, one-on-one conversation just fine, and their confusion or repeated “what?” clusters specifically around noisy rooms, groups, and phone calls. Someone with a primarily cognitive problem tends to lose the thread even in easy listening conditions. The two are genuinely hard to tell apart without testing, though, and untreated hearing loss can itself produce symptoms that look like cognitive decline — social withdrawal, apparent confusion, flattened conversation — which is exactly why a hearing test is a reasonable, low-cost first step before assuming a cognitive diagnosis. Read our OTC vs. prescription hearing aids guide to understand which route fits your situation, and see our does Medicare cover hearing aids guide for what’s actually reimbursable.

A quick health note

This guide is not medical advice, and dementia should always be diagnosed by a physician, not inferred from a blog post. If hearing loss came on suddenly, is in one ear only, or is accompanied by ear pain, drainage, or pulsing/one-sided tinnitus, see a hearing professional promptly rather than starting with an OTC device. OTC hearing aids are intended for adults 18 and over with perceived mild-to-moderate hearing loss; anyone with more complex hearing loss, or a caregiver managing a loved one with cognitive impairment, should involve an audiologist in the fitting process.

For more, see our best hearing aids for seniors, hearing aid apps, best hearing aid remote controls, does Medicare cover hearing aids, and best OTC hearing aids.

The bottom line

The 2024 Lancet Commission calls hearing loss the largest modifiable midlife risk factor for dementia, and the ACHIEVE trial gives that claim real trial evidence: 48% slower cognitive decline over 3 years in higher-risk older adults who got their hearing treated, rising to 58% in the highest-risk group. That is a strong reason to stop postponing a hearing aid purchase, not a guarantee for any one person. If you’re buying for your own hearing, pick a device with real follow-up support behind it, not just the cheapest self-fitting option. If you’re buying for a family member who already has a dementia diagnosis, optimize for simplicity and caregiver control over features: rechargeable batteries, a fixed professional fit, and remote adjustment so the person wearing the device never has to be the one operating it. Browse current hearing aid options on Amazon once you’ve settled on the right approach.

Frequently Asked Questions

Do hearing aids really help prevent dementia?

The evidence supports a strong link, not a guarantee. The 2024 Lancet Commission named hearing loss the single largest modifiable midlife risk factor for dementia, and the Johns Hopkins ACHIEVE trial, a 3-year randomized controlled trial of 977 adults aged 70 to 84, found that treating hearing loss slowed cognitive decline by 48% in participants who already had elevated dementia risk factors. Among the highest-risk quarter of participants, decline was 58% slower. The effect was not statistically significant in healthy volunteers with fewer risk factors, so the honest summary is: treating hearing loss appears to meaningfully protect cognition in older adults who are already at elevated risk, and there is no downside to treating it in anyone.

Were the hearing aids in the ACHIEVE trial regular OTC hearing aids?

No. The ACHIEVE trial used what researchers call 'best-practice hearing intervention': audiologist-administered hearing tests, clinically fitted prescription-grade devices, and ongoing professional follow-up, not self-fitting consumer devices. That does not mean OTC hearing aids can't help; it means the specific 48% figure was measured with professional fitting and support built in, which is one reason to still involve an audiologist or use a brand with real teleaudiology follow-up, such as Jabra Enhance or Signia, rather than a bare device with no support.

Can someone with dementia use a self-fitting OTC hearing aid?

It depends on the stage. OTC hearing aids are FDA-regulated for adults 18 and over with self-perceived mild-to-moderate hearing loss, and the entire self-fitting process assumes the user can operate a phone app and judge their own sound quality, both of which become unreliable as dementia progresses. For early-stage dementia with a supportive caregiver, an app-based OTC device with a caregiver-accessible remote adjustment feature can work well. For moderate-to-advanced dementia, a clinical audiologist visit is the safer route, because only a professional exam can separate genuine hearing loss from difficulty communicating the problem, and clinic-fitted aids can be programmed and locked to a fixed setting so the wearer never has to adjust anything themselves.

What features matter most when choosing hearing aids for a person with dementia?

Simplicity beats features. Prioritize rechargeable batteries over disposable ones (a person with dementia may swallow or lose small batteries, and cannot always feel the correct polarity), a device that can be set once and left alone rather than one that requires daily app adjustments, and if the budget allows, a platform with remote caregiver access such as ReSound Assist Live or Signia TeleCare, so a family member or audiologist can retune the device without an in-person visit. A physical remote control with large buttons, covered in our best hearing aid remote controls guide, is often easier for a caregiver to manage than a smartphone app.

Does Medicare cover hearing aids for a dementia patient?

No differently than for anyone else. Original Medicare Part A and B does not cover hearing aids or fitting exams, according to Medicare.gov, regardless of a dementia diagnosis. Some Medicare Advantage plans include a hearing aid benefit, and hearing aids are an eligible HSA/FSA expense. See our does Medicare cover hearing aids guide for the full breakdown, including which Advantage plans typically include an allowance.

What percentage of dementia cases are linked to hearing loss?

The 2024 Lancet Commission on dementia prevention estimated that hearing loss alone accounts for roughly 7% of the population-level risk for dementia, the largest single share among the 14 modifiable risk factors it identified across the life course (which together account for about 45% of dementia cases). That is a population-level statistic about risk, not a claim that any one person's hearing loss will cause dementia, or that any one hearing aid purchase prevents it.

What are the warning signs that hearing loss, not dementia, is the real problem?

Confusion in group settings, seeming to ignore people, repeating the same question, and social withdrawal are symptoms of both untreated hearing loss and early dementia, which is why they get mixed up. A rough sign favoring hearing loss: the person tracks conversation fine one-on-one in a quiet room but struggles badly in groups or with background noise, and asks people to repeat themselves specifically, rather than losing the thread of a conversation they clearly heard. Because the two conditions are genuinely hard to tell apart without testing, and because untreated hearing loss can itself look like early cognitive decline, a baseline hearing test is a reasonable first step before assuming the worst.